Carregant...

Exposure and response prevention helps adults with obsessive compulsive disorder who do not respond to pharmacological augmentation strategies

OBJECTIVE: Serotonin reuptake inhibitors (SRIs) are a first-line treatment for obsessive-compulsive disorder (OCD). Yet, most OCD patients on SRIs do not show excellent response, and recent studies show that augmenting SRIs with risperidone benefits a minority of patients. We evaluated the effective...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Clin Psychiatry
Autors principals: McLean, Carmen P., Zandberg, Laurie J., Van Meter, Page E., Carpenter, Joseph K., Simpson, Helen Blair, Foa, Edna B.
Format: Artigo
Idioma:Inglês
Publicat: 2015
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5135093/
https://ncbi.nlm.nih.gov/pubmed/26613263
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4088/JCP.14m09513
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!